Status:
UNKNOWN
Feasibility Study of Game Technology in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Lead Sponsor:
Ascentys Ltd
Conditions:
Dementia Alzheimers
Eligibility:
All Genders
55-79 years
Phase:
NA
Brief Summary
This study will test G:DATA, a simple computer game designed to diagnose Alzheimer's Disease, in three different groups of people, some of whom have Alzheimer's Disease. It will look at whether the re...
Detailed Description
Alzheimer's Disease is a type of dementia that causes progressive deterioration to memory, thinking and behaviour. It is currently thought to affect 50 million people globally, although 75% of those a...
Eligibility Criteria
Inclusion
- Aged between 55-79 years
- Willing and able to provide informed consen-
Exclusion
- A concurrent diagnosis of epilepsy
- A history of severe visual impairment, e.g. macular degeneration, diabetic reti-nopathy, as determined by the clinical team
- A history of head trauma
- Presence of Sleep Apnoea
- History of alcohol dependence
- History of illicit drug use
- Severe upper limb arthropathy
- The use of cognitive enhancing drugs e.g. cholinesterase inhibitors-
Key Trial Info
Start Date :
October 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06047340
Start Date
October 2 2023
End Date
December 31 2023
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hywel Dda University Health Board
Carmarthen, Wales, United Kingdom, SA31 3BB